This trial is testing a new drug, Vabomere, to see if it is safe and effective in children with serious bacterial infections.
- Bacterial Infection
11 Primary · 0 Secondary · Reporting Duration: From assent / consent until day 7 safety follow up call
Side Effects for
1 Treatment Group
Single dose IV meropenem-vaborbactam
1 of 1
67 Total Participants · 1 Treatment Group
Primary Treatment: Vabomere · No Placebo Group · Phase 1
Who is running the clinical trial?
Age < 18 · All Participants · 6 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is this investigation the first of its kind?
"Since 2016, there has been a significant body of research dedicated to Vabomere. Rempex (a subsidiary of Melinta Therapeutics) launched the initial trial in 2016 which included 60 participants and led to its Phase 1 drug approval. At present, 10 different investigations are actively taking place internationally across 30 cities within 15 nations." - Anonymous Online Contributor
Could you provide an exact figure of the participants enrolled in this research?
"To meet the requirements of this clinical trial, 60 participants must be recruited that fit specified inclusion criteria. Patients may take part in this medical study at Ronald Reagan UCLA Medical Center (Los Angeles) and Ann & Robert H. Lurie Children's Hospital of Chicago (Chicago)." - Anonymous Online Contributor
What diseases typically respond positively to Vabomere?
"Vabomere is mainly used to treat urinary tract infections, yet can be also utilised for treating communicable diseases, klebsiella pneumoniae, meningitis and select bacterial illnesses." - Anonymous Online Contributor
What precautions should be taken when utilizing Vabomere?
"At Power, we gave Vabomere a rating of 1 on our safety scale given the limited data from Phase 1 trials that suggests its efficacy and security." - Anonymous Online Contributor
Are there additional experiments utilizing Vabomere that have been conducted?
"Vabomere was first studied at University of Nebraska Medical Center in 2016 and there are currently 70 completed studies. 10 research projects are actively recruiting subjects, a majority of which located in Los Angeles." - Anonymous Online Contributor
How widely dispersed is the current clinical test?
"This clinical trial is taking place in multiple locations, including the Ronald Reagan UCLA Medical Center located in Los Angeles, California; Ann & Robert H. Lurie Children's Hospital of Chicago situated in Chicago, Illinois; and Rady Children's Hospital San Diego found in San Diego, New Jersey , among other healthcare facilities." - Anonymous Online Contributor
Are there any vacancies available in this research endeavor?
"According to clinicaltrials.gov, these experiments are ongoing and open for enrollment. The study was initially uploaded on July 1st 2016 with the most recent edit occurring August 9th 2021." - Anonymous Online Contributor